2024 Q2 Form 10-K Financial Statement

#000149315224014897 Filed on April 17, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $196.1K $3.412M $15.11M
YoY Change -95.91% 3468.66% 467.49%
Cost Of Revenue $20.10K $3.750M $14.02M
YoY Change -99.53% 5014.18% 841.78%
Gross Profit $176.0K -$337.4K $1.090M
YoY Change -65.73% -1612.87% -7.15%
Gross Profit Margin 89.75% -9.89% 7.21%
Selling, General & Admin $1.084M $1.068M $3.519M
YoY Change 24.78% 147.34% 64.93%
% of Gross Profit 616.08% 322.8%
Research & Development $0.00
YoY Change
% of Gross Profit 0.0%
Depreciation & Amortization $2.969K $14.59K $32.85K
YoY Change -8.76% 94.02% 9.22%
% of Gross Profit 1.69% 3.01%
Operating Expenses $1.150M $1.036M $3.746M
YoY Change 29.16% 135.8% 73.09%
Operating Profit -$973.9K -$1.373M -$2.655M
YoY Change 158.59% 229.33% 168.29%
Interest Expense -$127.7K -$430.0K -$1.811M
YoY Change -75.07% -38.26% 24.31%
% of Operating Profit
Other Income/Expense, Net $142.0K $40.00 $81.58K
YoY Change -137.43% -99.86% -93.05%
Pretax Income -$831.9K -$3.058M -$5.510M
YoY Change 10.03% -308.0% -3425.48%
Income Tax $13.20K $22.17K
% Of Pretax Income
Net Earnings -$831.9K -$3.107M -$5.660M
YoY Change 9.8% -308.61% -3939.83%
Net Earnings / Revenue -424.15% -91.05% -37.45%
Basic Earnings Per Share -$0.02 $0.14
Diluted Earnings Per Share -$0.02 -$0.08 -$0.15
COMMON SHARES
Basic Shares Outstanding 42.50M shares 38.97M shares 38.45M shares
Diluted Shares Outstanding 43.09M shares 38.45M shares

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.351M $1.223M $1.223M
YoY Change -15.43% 719.47% 719.47%
Cash & Equivalents $387.9K $174.9K
Short-Term Investments $962.6K $1.048M $1.048M
Other Short-Term Assets $545.8K $1.841M $1.841M
YoY Change -77.38% -0.8% -0.8%
Inventory $719.3K $974.9K $974.9K
Prepaid Expenses
Receivables $1.946M $1.759M $1.759M
Other Receivables $103.3K $952.9K $952.9K
Total Short-Term Assets $4.837M $6.751M $6.751M
YoY Change -31.33% 69.19% 69.19%
LONG-TERM ASSETS
Property, Plant & Equipment $3.676K $532.7K $532.7K
YoY Change -92.11% 3495.17% 209.36%
Goodwill $748.0K $748.0K
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $547.4K $0.00 $0.00
YoY Change -100.0% -100.0%
Other Assets $112.2K $67.13K $67.13K
YoY Change 231.87% 117.31% 117.32%
Total Long-Term Assets $4.476M $4.178M $4.178M
YoY Change 19.24% 1.3% 1.3%
TOTAL ASSETS
Total Short-Term Assets $4.837M $6.751M $6.751M
Total Long-Term Assets $4.476M $4.178M $4.178M
Total Assets $9.313M $10.93M $10.93M
YoY Change -13.75% 34.68% 34.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $954.3K $964.1K $964.1K
YoY Change 66.41% 12.04% 12.04%
Accrued Expenses $529.7K $933.2K $933.2K
YoY Change 336.84% 683.99% 205.49%
Deferred Revenue $41.46K $210.3K
YoY Change -93.06% 161.34%
Short-Term Debt $2.695M $2.561M $2.561M
YoY Change -18.49% 117.68% 117.68%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.537M $4.802M $4.802M
YoY Change -7.79% -23.0% -23.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $196.1K $257.9K $257.9K
YoY Change 38.01%
Total Long-Term Liabilities $196.1K $257.9K $257.9K
YoY Change 38.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.537M $4.802M $4.802M
Total Long-Term Liabilities $196.1K $257.9K $257.9K
Total Liabilities $4.733M $5.817M $5.817M
YoY Change -6.5% -6.73% -6.73%
SHAREHOLDERS EQUITY
Retained Earnings -$25.43M -$22.98M
YoY Change 33.08% 33.04%
Common Stock $44.58K $39.15K
YoY Change 15.02% 5.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.580M $5.112M $5.112M
YoY Change
Total Liabilities & Shareholders Equity $9.313M $10.93M $10.93M
YoY Change -13.75% 34.68% 34.68%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$831.9K -$3.107M -$5.660M
YoY Change 9.8% -308.61% -3939.83%
Depreciation, Depletion And Amortization $2.969K $14.59K $32.85K
YoY Change -8.76% 94.02% 9.22%
Cash From Operating Activities -$740.4K -$940.9K -$4.783M
YoY Change -62.6% 199.2% 113.14%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $45.45K $80.83K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$300.00 -$287.3K -$237.8K
YoY Change -102.88% 493.66% -83.46%
Cash From Investing Activities -$300.00 -$332.7K -$318.6K
YoY Change -98.82% 587.56% -77.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.082M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 840.5K 1.190M 5.096M
YoY Change -1052.74% 368.7% 82.09%
NET CHANGE
Cash From Operating Activities -740.4K -940.9K -4.783M
Cash From Investing Activities -300.0 -332.7K -318.6K
Cash From Financing Activities 840.5K 1.190M 5.096M
Net Change In Cash 99.82K -83.58K -5.200K
YoY Change -104.77% -23.29% -99.5%
FREE CASH FLOW
Cash From Operating Activities -$740.4K -$940.9K -$4.783M
Capital Expenditures $0.00 $45.45K $80.83K
Free Cash Flow -$740.4K -$986.3K -$4.864M
YoY Change -63.27% 116.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001329606
CY2023Q4 CETY Lease Receivable Asset Current
LeaseReceivableAssetCurrent
usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
usd
CY2022Q4 CETY Intangible Assets Net
IntangibleAssetsNet
usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
usd
CY2022Q4 CETY Operating Lease Liabilities Noncurrent
OperatingLeaseLiabilitiesNoncurrent
usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
usd
CY2023 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
usd
CY2023 CETY Financing Fees
FinancingFees
usd
CY2023 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
usd
CY2023 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
usd
CY2023 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2022 CETY Payments From Loans Receivable
PaymentsFromLoansReceivable
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
usd
CY2022 us-gaap Stock Issued1
StockIssued1
usd
CY2022 CETY Warrants Issued In Conjunction For Convertible Notes Payable
WarrantsIssuedInConjunctionForConvertibleNotesPayable
usd
CY2023 CETY Forgiveness Debt
ForgivenessDebt
usd
CY2022Q4 CETY Accounts Receivable Rp
AccountsReceivableRp
usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
usd
CY2022Q4 CETY Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Intrincic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingIntrincicValue
usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
shares
CY2023Q4 CETY Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Exercise Price Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageExercisePriceExpired
CY2023 CETY Share Based Compensation Arrangement By Share Based Payment Award Non Option Intrinsic Value Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionIntrinsicValueExpired
usd
CY2023 CETY Share Based Compensation Arrangement By Share Based Payment Award Non Option Intrinsic Value Addition
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionIntrinsicValueAddition
usd
CY2023 CETY Share Based Compensation Arrangement By Share Based Payment Award Non Option Intrinsic Value Additions
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionIntrinsicValueAdditions
usd
CY2023Q4 CETY Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Intrincic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingIntrincicValue
usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
20721204 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
42495453 shares
CY2023 dei Auditor Firm
AuditorFirmId
5854
CY2023 dei Auditor Name
AuditorName
TAAD, LLP
CY2023 dei Auditor Location
AuditorLocation
Diamond Bar, California
CY2023Q4 us-gaap Cash
Cash
174851 usd
CY2022Q4 us-gaap Cash
Cash
149272 usd
CY2022Q4 CETY Lease Receivable Asset Current
LeaseReceivableAssetCurrent
217584 usd
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
11000 usd
CY2022Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
204556 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
752066 usd
CY2023Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
200826 usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
116000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
974894 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
500586 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
6750728 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
3990136 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78688 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14816 usd
CY2023Q4 us-gaap Goodwill
Goodwill
747976 usd
CY2022Q4 us-gaap Goodwill
Goodwill
747976 usd
CY2023Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
1468709 usd
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
1468709 usd
CY2023Q4 CETY Intangible Assets Net
IntangibleAssetsNet
12914 usd
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
561656 usd
CY2023Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
902354 usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
684770 usd
CY2023Q4 CETY License Noncurrent
LicenseNoncurrent
354322 usd
CY2022Q4 CETY License Noncurrent
LicenseNoncurrent
354322 usd
CY2023Q4 CETY Patents
Patents
91817 usd
CY2022Q4 CETY Patents
Patents
103693 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
453970 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
157359 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
67133 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
30892 usd
CY2023Q4 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
4177883 usd
CY2022Q4 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
4109377 usd
CY2023Q4 us-gaap Assets
Assets
10928611 usd
CY2022Q4 us-gaap Assets
Assets
8114329 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
586372 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
119030 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
210310 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
80475 usd
CY2023Q4 CETY Warranty Liability Current
WarrantyLiabilityCurrent
100000 usd
CY2022Q4 CETY Warranty Liability Current
WarrantyLiabilityCurrent
100000 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
33000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
33000 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
588178 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
346807 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
186436 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
626033 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
998820 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
70056 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
326805 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1934956 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
3092055 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4801523 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6236132 usd
CY2023Q4 CETY Operating Lease Liabilities Noncurrent
OperatingLeaseLiabilitiesNoncurrent
209986 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
257890 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5059413 usd
CY2022Q4 us-gaap Liabilities
Liabilities
6236132 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2023Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
47904 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39152455 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39152455 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37174879 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37174879 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
39152 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
37175 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
28251621 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19278230 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-196827 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-160673 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22984163 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17276536 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
5111982 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1878196 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
757216 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5869198 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1878196 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10928611 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8114328 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15113463 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2663212 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
684893 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
400322 usd
CY2023 us-gaap Salaries And Wages
SalariesAndWages
1671071 usd
CY2022 us-gaap Salaries And Wages
SalariesAndWages
782657 usd
CY2023 CETY Facility Lease And Maintenance
FacilityLeaseAndMaintenance
401293 usd
CY2022 CETY Facility Lease And Maintenance
FacilityLeaseAndMaintenance
349610 usd
CY2023 CETY Consulting
Consulting
199594 usd
CY2022 CETY Consulting
Consulting
119896 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26692 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30076 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
3745662 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
2163947 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-2655408 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-989751 usd
CY2023 us-gaap Other Income
OtherIncome
81583 usd
CY2022 us-gaap Other Income
OtherIncome
55403 usd
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
326539 usd
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-331495 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1124654 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2556916 usd
CY2023 us-gaap Financing Interest Expense
FinancingInterestExpense
2137649 usd
CY2022 us-gaap Financing Interest Expense
FinancingInterestExpense
1125395 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5509589 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
165678 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22173 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18283 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-5531762 usd
CY2022 us-gaap Profit Loss
ProfitLoss
147395 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
127961 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-5659723 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
147395 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-36155 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-160673 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5695878 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13278 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38447916 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38447916 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27681722 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27681722 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1721712 usd
CY2022 CETY Stock Issued During Period Value For Warrant Conversion
StockIssuedDuringPeriodValueForWarrantConversion
471278 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1202800 usd
CY2022 CETY Stock Issued During Period Value For Note Conversion
StockIssuedDuringPeriodValueForNoteConversion
1548904 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 usd
CY2022 CETY Stock Issued During Period Value Issued For S1
StockIssuedDuringPeriodValueIssuedForS1
291145 usd
CY2022 CETY Stock Issued During Period Value Contribution To Capital
StockIssuedDuringPeriodValueContributionToCapital
80000 usd
CY2022 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-160673 usd
CY2022 CETY Net Loss
NetLoss
166454 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1878196 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1878196 usd
CY2023 CETY Adjustments To Additional Paid In Capital Warrants Issued In Conjunction For Debt
AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionForDebt
609619 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
76100 usd
CY2023 CETY Stock Issued During Period Value Issued For S1
StockIssuedDuringPeriodValueIssuedForS1
3900000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
805445 usd
CY2023 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
64225 shares
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
-4 usd
CY2023 CETY Stock Issued During Period Value Issued For Debt Conversion
StockIssuedDuringPeriodValueIssuedForDebtConversion
666250 usd
CY2023 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-57850 usd
CY2023 CETY Fair Value Of Nci From Acquisition
FairValueOfNciFromAcquisition
650951 usd
CY2023 CETY Stock Issued During Period Value For Warrant Conversion
StockIssuedDuringPeriodValueForWarrantConversion
987203 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
261639 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
72000 usd
CY2023 CETY Stock Issued During Period Value For Series E Preferred
StockIssuedDuringPeriodValueForSeriesEPreferred
3210206 usd
CY2023 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
47904 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-5531762 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5869198 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5869198 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-5659723 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
147395 usd
CY2023 us-gaap Depreciation
Depreciation
32850 usd
CY2022 us-gaap Depreciation
Depreciation
30076 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
148100 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1124654 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2556916 usd
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
846682 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
350470 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5467 usd
CY2022 CETY Financing Fees
FinancingFees
416014 usd
CY2022 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
204556 usd
CY2023 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-326539 usd
CY2022 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
331495 usd
CY2023 CETY Increase Decrease In Right Of Use Asset1
IncreaseDecreaseInRightOfUseAsset1
-297201 usd
CY2022 CETY Increase Decrease In Right Of Use Asset1
IncreaseDecreaseInRightOfUseAsset1
238248 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
371240 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-234816 usd
CY2022 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
81756 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-183368 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
38394 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-561597 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
312460 usd
CY2023 CETY Decrease Increase In Accrued Interest
DecreaseIncreaseInAccruedInterest
26771 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
435417 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
557436 usd
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-543036 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4091 usd
CY2022 CETY Decrease Increase In Accrued Interest
DecreaseIncreaseInAccruedInterest
155162 usd
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
127350 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
56435 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4783077 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2244133 usd
CY2022 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
116000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-318602 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1437123 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
68207 usd
CY2023 CETY Proceeds From Notes Payable And Lines Of Credit
ProceedsFromNotesPayableAndLinesOfCredit
2605539 usd
CY2022 CETY Proceeds From Notes Payable And Lines Of Credit
ProceedsFromNotesPayableAndLinesOfCredit
2180460 usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
987204 usd
CY2023 CETY Payments From Loans Receivable
PaymentsFromLoansReceivable
-84720 usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1675535 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
807312 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3094555 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1493945 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5096483 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2798885 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30776 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-160673 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25580 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1043043 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
149272 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1192315 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
174851 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
149272 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
257149 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
671510 usd
CY2023 CETY Discount On Derivatives
DiscountOnDerivatives
239800 usd
CY2022 CETY Discount On Derivatives
DiscountOnDerivatives
471278 usd
CY2023 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
261639 usd
CY2023 us-gaap Stock Issued1
StockIssued1
3210206 usd
CY2023 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
666250 usd
CY2022 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1548904 usd
CY2023 CETY Warrants Issued In Conjunction For Convertible Notes Payable
WarrantsIssuedInConjunctionForConvertibleNotesPayable
609619 usd
CY2022 CETY Forgiveness Debt
ForgivenessDebt
80000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5869198 usd
CY2023Q4 CETY Working Capital Deficit
WorkingCapitalDeficit
-1949206 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22984163 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4783077 usd
CY2023 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
8000000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_ztuNwCiI6DW1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zylPLYVPZLgd">Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates may be materially different from actual financial results. Significant estimates include the recoverability of long-lived assets, the collection of accounts receivable and valuation of inventory and reserves.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
95000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
95000 usd
CY2023Q4 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
247500 usd
CY2022Q4 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
247500 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
934344 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
897808 usd
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2023 CETY Final Payment Percentage
FinalPaymentPercentage
0.10 pure
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
33000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
33000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
210310 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
80475 usd
CY2023Q1 CETY Business Combination Contingent Non Controlling Interest Percentage
BusinessCombinationContingentNonControllingInterestPercentage
0.51 pure
CY2023Q1 us-gaap Derivative Net Assets Percentage
DerivativeNetAssetsPercentage
1 pure
CY2023 CETY Weighted Average Number Shares Outstanding Adjustment
WeightedAverageNumberSharesOutstandingAdjustment
39152455 shares
CY2023 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
38447916 shares
CY2022 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
27681722 shares
CY2023 CETY Weighted Average Number Of Diluted Shares Outstanding1
WeightedAverageNumberOfDilutedSharesOutstanding1
38227965 shares
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15113463 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2663212 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1090254 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1174196 usd
CY2023Q4 CETY Selected Financial Assets
SelectedFinancialAssets
11511037 usd
CY2022Q4 CETY Selected Financial Assets
SelectedFinancialAssets
8114329 usd
CY2023 CETY Total Sales Selected Financial
TotalSalesSelectedFinancial
15113463 usd
CY2022 CETY Total Sales Selected Financial
TotalSalesSelectedFinancial
2567596 usd
CY2023 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0 usd
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0 usd
CY2023 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
On December 22, 2018 H.R. 1, originally known as the Tax Cuts and Jobs Act, (the “Tax Act”) was enacted. Among the significant changes to the U.S. Internal Revenue Code, the Tax Act lowers the U.S. federal corporate income tax rate (“Federal Tax Rate”) from 35% to 21% effective January 1, 2018. The Company will compute its income tax expense for the year ended December 31, 2022 using a Federal Tax Rate of 21% and an estimated state of California rate of 9%.
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
15737415 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
4727224 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
4727224 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1430337 usd
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84C_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zyLjKUmazAJe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zyiYDpAkFHe7">Reclassification</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on reported income, total assets, or stockholders’ equity as previously reported.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
11000 usd
CY2023Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
1362130 usd
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
1388567 usd
CY2023Q4 CETY Accounts Receivable Rp
AccountsReceivableRp
491774 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
95000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
95000 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1758904 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1293567 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
1909238 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
1389394 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
934344 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
897808 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
974894 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
500586 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1509025 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1430260 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1415444 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78688 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14816 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
26692 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
30076 usd
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
747976 usd
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
747976 usd
CY2023Q4 us-gaap Investments
Investments
1468709 usd
CY2022Q4 us-gaap Investments
Investments
1468709 usd
CY2023Q4 CETY License
License
354322 usd
CY2022Q4 CETY License
License
354322 usd
CY2023Q4 CETY Patents Gross
PatentsGross
190789 usd
CY2022Q4 CETY Patents Gross
PatentsGross
190789 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
98972 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
87096 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2682893 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2674700 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11876 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11876 usd
CY2023 us-gaap Interest Income Operating
InterestIncomeOperating
58273 usd
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
104775 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
102370 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
433936 usd
CY2022Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
16660 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
586372 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
119030 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
626033 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
998820 usd
CY2022 CETY Gain On Debt Payment
GainOnDebtPayment
2556916 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1697757 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3156528 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
308216 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
262331 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
71017 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
326804 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1934956 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3092055 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
588178 usd
CY2022Q3 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
Effective August 5, 2022, Shuya entered a 48-month lease for a natural gas recycle station from Leishen (the 41% shareholder of Shuya), including the operating rights and use rights of all the assets and equipment in the station. The annual rent is approximately $64,290, to be paid each year in advance, however, it has not been paid since the lease commenced. Effective August 5, 2022, Shuya entered another 48-month lease for leasing sewage treatment land from Leishen to operate the natural gas recycling station. The annual rent is approximately $17,137, to be paid each year in advance, which has not been fully paid since the lease commenced.
CY2023 us-gaap Lease Cost
LeaseCost
401293 usd
CY2022 us-gaap Lease Cost
LeaseCost
349610 usd
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
shares of Common Stock such that each (40) shares of Old Common Stock shall be reclassified as and combined into one (1) share of New Common Stock
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
375875 shares
CY2022Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
3.20
CY2022Q1 us-gaap Legal Fees
LegalFees
45498 usd
CY2022Q2 us-gaap Legal Fees
LegalFees
34500 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
3745 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39152455 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Dividend And Interest Receivable
DividendAndInterestReceivable
47904 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
325243 shares
CY2022Q4 CETY Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageExercisePrice
1.60
CY2022 CETY Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Remaining Life Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageRemainingLifeOutstanding
P3Y11M26D
CY2023 CETY Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Additions
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedAdditions
425438 shares
CY2023Q4 CETY Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Exercise Price Addition
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageExercisePriceAddition
1.60
CY2023 CETY Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Remaining Life Addition
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageRemainingLifeAddition
P4Y2M1D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
26701 shares
CY2023Q4 CETY Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Exercise Price Additions
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageExercisePriceAdditions
5.00
CY2023 CETY Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Remaining Life Additions
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageRemainingLifeAdditions
P3Y10M24D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
707280 shares
CY2023Q4 CETY Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Exercise Price Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageExercisePriceExercised
1.60
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
70102 shares
CY2023Q4 CETY Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageExercisePrice
2.90
CY2023 CETY Share Based Compensation Arrangement By Share Based Payment Award Non Option Weighted Average Remaining Life Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionWeightedAverageRemainingLifeOutstanding
P3Y8M15D
CY2023Q4 CETY Warrant Liability
WarrantLiability
0 usd
CY2022Q4 CETY Warrant Liability
WarrantLiability
0 usd
CY2023Q4 CETY Principal Amount Outstanding On Warrant
PrincipalAmountOutstandingOnWarrant
100000 usd
CY2022Q4 CETY Principal Amount Outstanding On Warrant
PrincipalAmountOutstandingOnWarrant
100000 usd
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
0 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
22173 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22173 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.068 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.001 pure
CY2023 CETY Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Permanent Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRatePermanentDifferential
0.002 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.280 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.004 pure
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
5686 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7021555 usd
CY2023Q4 CETY Operating Lease Liabilities Net Of Right Of Use Assets
OperatingLeaseLiabilitiesNetOfRightOfUseAssets
2479 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
7029720 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
7029720 usd
CY2023Q4 CETY Net Operating Loss Carryforwards Federal Income Tax
NetOperatingLossCarryforwardsFederalIncomeTax
30080000.00 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
87148000000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7030000.00 usd
CY2023 CETY Minimum Annual After Tax Profit
MinimumAnnualAfterTaxProfit
0.10 pure
CY2023 CETY Surplus Reserve Percentage
SurplusReservePercentage
0.50 pure
CY2023 CETY After Tax Profit Percentage
AfterTaxProfitPercentage
0.50 pure
CY2023 CETY After Tax Income Percentage
AfterTaxIncomePercentage
0.10 pure
CY2023 CETY Percentage Of Total Sales
PercentageOfTotalSales
0.15 pure

Files In Submission

Name View Source Status
0001493152-24-014897-index-headers.html Edgar Link pending
0001493152-24-014897-index.html Edgar Link pending
0001493152-24-014897.txt Edgar Link pending
0001493152-24-014897-xbrl.zip Edgar Link pending
aud_001.jpg Edgar Link pending
aud_002.jpg Edgar Link pending
cety-20231231.xsd Edgar Link pending
ex10-136.htm Edgar Link pending
ex10-137.htm Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex23-1_001.jpg Edgar Link pending
ex23-1_002.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-13.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
form10-k_002.jpg Edgar Link pending
form10-k_003.jpg Edgar Link pending
form10-k_004.jpg Edgar Link pending
form10-k_007.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
cety-20231231_def.xml Edgar Link unprocessable
cety-20231231_lab.xml Edgar Link unprocessable
cety-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cety-20231231_cal.xml Edgar Link unprocessable